These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 26066379)

  • 1. Management of high grade dysplasia in Barrett's oesophagus with underlying oesophageal varices: A retrospective study.
    Palmer WC; Di Leo M; Jovani M; Heckman MG; Diehl NN; Iyer PG; Wolfsen HC; Wallace MB
    Dig Liver Dis; 2015 Sep; 47(9):763-8. PubMed ID: 26066379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes of patients with Barrett's esophagus and high-grade dysplasia or early cancer treated with endoluminal therapies with intention to complete eradication.
    Guarner-Argente C; Buoncristiano T; Furth EE; Falk GW; Ginsberg GG
    Gastrointest Endosc; 2013 Feb; 77(2):190-9. PubMed ID: 23317687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Band Ligation Can Be Used to Treat Barrett's Esophagus and Concurrent Esophageal Varices: A Case Series.
    Hartgerink C; Nimri FM; Zuchelli T; Jafri SM; Piraka C
    Dig Dis Sci; 2023 Apr; 68(4):1381-1385. PubMed ID: 36131048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only--what is the clinical significance?
    Meining A; Ott R; Becker I; Hahn S; Mühlen J; Werner M; Höfler H; Classen M; Heldwein W; Rösch T
    Gut; 2004 Oct; 53(10):1402-7. PubMed ID: 15361485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
    Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
    Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation in Barrett's esophagus with dysplasia.
    Shaheen NJ; Sharma P; Overholt BF; Wolfsen HC; Sampliner RE; Wang KK; Galanko JA; Bronner MP; Goldblum JR; Bennett AE; Jobe BA; Eisen GM; Fennerty MB; Hunter JG; Fleischer DE; Sharma VK; Hawes RH; Hoffman BJ; Rothstein RI; Gordon SR; Mashimo H; Chang KJ; Muthusamy VR; Edmundowicz SA; Spechler SJ; Siddiqui AA; Souza RF; Infantolino A; Falk GW; Kimmey MB; Madanick RD; Chak A; Lightdale CJ
    N Engl J Med; 2009 May; 360(22):2277-88. PubMed ID: 19474425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia.
    Pouw RE; Wirths K; Eisendrath P; Sondermeijer CM; Ten Kate FJ; Fockens P; Devière J; Neuhaus H; Bergman JJ
    Clin Gastroenterol Hepatol; 2010 Jan; 8(1):23-9. PubMed ID: 19602454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
    Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus.
    Neuhaus H; Terheggen G; Rutz EM; Vieth M; Schumacher B
    Endoscopy; 2012 Dec; 44(12):1105-13. PubMed ID: 22968641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation.
    Morris CD; Byrne JP; Armstrong GR; Attwood SE
    Br J Surg; 2001 Oct; 88(10):1357-62. PubMed ID: 11578292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular evaluation of ablative therapy of Barrett's oesophagus.
    Hage M; Siersema PD; Vissers KJ; Steyerberg EW; Haringsma J; Kuipers EJ; van Dekken H
    J Pathol; 2005 Jan; 205(1):57-64. PubMed ID: 15586364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients.
    Pouw RE; Seewald S; Gondrie JJ; Deprez PH; Piessevaux H; Pohl H; Rösch T; Soehendra N; Bergman JJ
    Gut; 2010 Sep; 59(9):1169-77. PubMed ID: 20525701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of endoscopic surveillance of Barrett's esophagus on survival of patients with esophageal adenocarcinoma].
    Incarbone R; Bonavina L; Bassi F; Peracchia A
    Chir Ital; 2002; 54(5):591-6. PubMed ID: 12469454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification of Barrett's oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study.
    Ross-Innes CS; Chettouh H; Achilleos A; Galeano-Dalmau N; Debiram-Beecham I; MacRae S; Fessas P; Walker E; Varghese S; Evan T; Lao-Sirieix PS; O'Donovan M; Malhotra S; Novelli M; Disep B; Kaye PV; Lovat LB; Haidry R; Griffin M; Ragunath K; Bhandari P; Haycock A; Morris D; Attwood S; Dhar A; Rees C; Rutter MD; Ostler R; Aigret B; Sasieni PD; Fitzgerald RC;
    Lancet Gastroenterol Hepatol; 2017 Jan; 2(1):23-31. PubMed ID: 28404010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consistency of a high-grade dysplasia diagnosis in Barrett's oesophagus: a Dutch nationwide cohort study.
    Verbeek RE; van Oijen MG; ten Kate FJ; Vleggaar FP; van Baal JW; Siersema PD
    Dig Liver Dis; 2014 Apr; 46(4):318-22. PubMed ID: 24388501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
    Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
    Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of 8-hydroxydeoxyguanosine in oesophageal tissues and tumours.
    Räsänen JV; Sihvo EI; Ahotupa MO; Färkkilä MA; Salo JA
    Eur J Surg Oncol; 2007 Dec; 33(10):1164-8. PubMed ID: 17467227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
    Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
    Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial.
    van Vilsteren FG; Pouw RE; Seewald S; Alvarez Herrero L; Sondermeijer CM; Visser M; Ten Kate FJ; Yu Kim Teng KC; Soehendra N; Rösch T; Weusten BL; Bergman JJ
    Gut; 2011 Jun; 60(6):765-73. PubMed ID: 21209124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.